Danish pharmaceutical company enters the Middle East
![Foto: Colourbox](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article4740472.ece/ALTERNATES/schema-16_9/Israel.jpg)
The Danish company Azanta is now entering the Middle Eastern market through a collaboration deal with Israeli company Lavi. The deal stipulates that Lavi will have the exclusive distribution of the two Azanta drugs Nimoral and Zybrestat in Israel.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.